Market Tracker

07/26 4:35am ET

TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

5.75
Delayed Data
As of Jul 25
 -0.14 / -2.38%
Today’s Change
3.50
Today|||52-Week Range
8.30
-0.35%
Year-to-Date

Today’s Trading

Previous close5.89
Today’s open6.02
Day’s range5.55 - 6.09
Volume2,800,195
Average volume (3 months)3,285,833
Market cap$1.2B
Dividend yield--
Data as of 07/25/2017

Growth & Valuation

Earnings growth (last year)+6.12%
Earnings growth (this year)--
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)-3.90%
P/E ratioNM
Price/Sales58.45
Price/Book9.09

Competitors

 Today’s
change
Today’s
% change
DERMDermira Inc-0.36-1.23%
XNCRXencor Inc-0.24-0.99%
EGRXEagle Pharmaceutical...-2.76-3.79%
AIMTAimmune Therapeutics...-0.35-1.59%
Data as of 07/25/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$19.4M
Annual profit (last year)-$89.9M
Net profit margin-464.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts